With effect from April 18, 2016, the unit rights in NeuroVive Pharmaceutical AB (publ) will be admitted to trading on the list for Equity rights. The trading will continue up until and including April 28, 2016.
| Instrument: | Unit rights |
| Short name: | NVP UR |
| Round lot: | 1 |
| Clearing | Bilateral settlement at Euroclear Sweden |
| ISIN code: | SE0008241863 |
| Orderbook ID: | 121154 |
| Market Segment / no: | OMX STO Eq.rights,Subs.Opt, Int. shares/1 |
| Tick Size / no: | Other Equities/227 |
| MIC Code: | XSTO |
With effect from April 18, 2016, the paid subscription units in NeuroVive Pharmaceutical AB (publ) will be admitted to trading on the list for Equity rights. The trading will continue until further notice.
| Instrument: | Paid subscription units |
| Short name: | NVP BTU |
| Round lot: | 1 |
| Clearing | Bilateral settlement at Euroclear Sweden |
| ISIN code: | SE0008241871 |
| Orderbook ID: | 121155 |
| Market Segment / no: | OMX STO Eq.rights,Subs.Opt, Int. shares/1 |
| Tick Size / no: | Other Equities/227 |
| MIC Code: | XSTO |
For further information concerning this exchange notice please contact Andreas Jensen or Eva Norling, telephone +46 8 405 60 00, or iss@nasdaqomx.com
NASDAQ OMX Stockholm AB